Brief: Voyager Therapeutics Says Peter P. Pfreundschuh Resigned From His Position Of Chief Financial Officer Effective On April 12, 2024
02/04/2024 21:40
April 2 (Reuters) - Voyager Therapeutics Inc VYGR.O :
* VOYAGER THERAPEUTICS INC- ON APRIL 1 CO AND PETER P.
PFREUNDSCHUH ENTERED INTO A TRANSITION, SEPARATION AND RELEASE
OF CLAIMS AGREEMENT
* VOYAGER THERAPEUTICS INC- PURSUANT TO AGREEMENT
PFREUNDSCHUH
RESIGNED FROM HIS POSITION OF CHIEF FINANCIAL OFFICER EFFECTIVE
ON APRIL 12, 2024
Source text for Eikon: ID:n0001104659-24-042502
Further company coverage: VYGR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Voyager Therapeutics
See all newsBrief: Voyager Names Robin Swartz As President; Expected To Succeed As CEO In Q1 2027
Voyager Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Voyager Therapeutics Q2 collaboration revenue falls, net loss narrows
Brief: Voyager Therapeutics Q2 Net Income USD -24.473 Million
Voyager Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview